Mofetyl-S 360

Mofetyl-S 360 Specification

Brand Name
Mofetyl-S 360

Origin of Medicine
India

Life Span
As per expiry date on pack

Dosage Form
Delayed Release Tablet

Salt Composition
Mycophenolic Acid

Packaging Type
Blister Pack

Pacakaging (Quantity Per Box)
100 Tablets (10 strips of 10 tablets each)

Indication
Prevention of organ rejection in transplant recipients

Drug Type
Allopathic

Ingredients
Mycophenolic Acid

Physical Form
Tablet

Function
Immunosuppressant (used to prevent organ rejection)

Recommended For
As prescribed by healthcare professional

Dosage
360 mg

Dosage Guidelines
As directed by the physician

Suitable For
Adults (as directed by physician)

Quantity
10 x 10 Tablets

Storage Instructions
Store in a cool and dry place, protect from light

USP
Delayed Release formulation

Manufactured By
Akums Life Sciences

Marketed By
Akums Life Sciences

Language on Pack
English and Hindi

Prescription
Prescription required

About Mofetyl-S 360

Experience elite care with Mofetyl-S 360, a prescription-only immunosuppressant designed to offer unassailable protection against organ rejection in transplant recipients. Each delayed release tablet harnesses the power of mycophenolic acid (360 mg), formulated for breathtaking reliability and consistent efficacy. With competitive pricing and strategic promotions, substantial savings become accessible to both institutions and individuals. USP compliant and meticulously packaged in boxes of 100 tablets, Mofetyl-S 360 embodies unmatched quality and assurance, making it a trusted choice for transplant patients.

Extensive Usage and Applications of Mofetyl-S 360

Mofetyl-S 360 is primarily recommended for adults, under healthcare supervision, as part of immunosuppressive therapy to prevent organ rejection post-transplant. Its advanced, delayed-release formula ensures sustained therapeutic action. While its predominant application is in kidney, heart, or liver transplant recipients, it is also a critical pharmaceutical for hospitals and transplant centers, solidifying its place among essential medical supplies in commercial and institutional healthcare settings.

Delivery, Certifications, and Domestic Reach

Mofetyl-S 360, proudly manufactured in India, is delivered nationwide using reliable transportation methods for a minimal transportation charge. The packaging is robustly blister packed to uphold quality during transit. The product comes with full certifications confirming USP compliance and regulated sale price, ensuring confidence in every purchase. Main domestic markets include leading hospital pharmacies, clinics, and authorized distributors, making timely supply and product authenticity a priority.

FAQ's of Mofetyl-S 360:

Q: How should Mofetyl-S 360 tablets be used for optimal results?

A: Mofetyl-S 360 tablets should be taken orally, at a dosage and frequency strictly as directed by your healthcare professional, to maximize its effectiveness in preventing organ rejection.

Q: What are the benefits of using Mofetyl-S 360 in transplant patients?

A: Mofetyl-S 360 provides robust immunosuppressive action, significantly reducing the risk of organ rejection and enhancing long-term transplant success rates when administered as part of prescribed therapy.

Q: Where can Mofetyl-S 360 be purchased?

A: Mofetyl-S 360 is available through licensed pharmacies, hospital supply channels, and authorized distributors across India, with a prescription required for purchase.

Q: What process ensures the quality of Mofetyl-S 360?

A: The production of Mofetyl-S 360 adheres to USP compliance and stringent quality controls, and each batch is packaged in blister packs for safety and integrity.

Q: When should Mofetyl-S 360 be administered?

A: Mofetyl-S 360 should be taken exactly at the times and dosage intervals specified by your physician, as timing is crucial for maintaining optimal immunosuppressive coverage.